Robin Stocksworth – Medium

Robin Stocksworth

Robin Stocksworth

Actinogen Medical Ltd. Shows Positive Pre-Trial Results

Australian biotech Actinogen Medical is listed on the ASX and is working on its main product, Xanamem, an 11β-HSD1 inhibitor that is…

Jul 29

Actinogen Medical Ltd. Shows Positive Pre-Trial Results

Jul 29

Robin Stocksworth

Actinogen Medical (ASX: ACW) Set to Cure Depression and Alzheimer’s’

To effectively treat depression, a multifaceted approach is often recommended, combining medication, therapy, lifestyle changes, and…

Jul 25

Jul 25

Robin Stocksworth

Getting To Know Actinogen Medical (ASX: ACW) Ahead of Trial Results this August 2024

Worldwide, at least 55 million people are believed to be living with Alzheimer’s disease or other dementias. If breakthroughs are not…

Jul 24

Getting To Know Actinogen Medical (ASX: ACW) Ahead of Trial Results this August 2024

Jul 24

Robin Stocksworth

OncoSil Medical (ASX: OSL): Promising Developments in Pancreatic Cancer Treatment

OncoSil Medical is a company developing a novel treatment for locally advanced, unresectable pancreatic cancer, a particularly aggressive…

Jul 8

OncoSil Medical (ASX: OSL): Promising Developments in Pancreatic Cancer Treatment

Jul 8

Robin Stocksworth

Upcoming Results for Actinogen Medical’s Phase 2a XanaCIDD Depression Trial

Actinogen Medical ($ACW) has recently announced that results for their Phase 2a XanaCIDD clinical trial in patients with cognitive…

Jul 5

Upcoming Results for Actinogen Medical’s Phase 2a XanaCIDD Depression Trial

Jul 5

Robin Stocksworth

Are King Charles III’s Pancreatic Cancer Claims True?

In late March 2024, weeks after Buckingham Palace announced King Charles III was suffering from an unspecified form of cancer, celebrity…

Apr 3

Are King Charles III’s Pancreatic Cancer Claims True?

Apr 3

Robin Stocksworth

Localised Radiation Treatment May Be the only hope for King Charles in His Greatest Battle Yet

Speculation Surrounds King Charles’ Health

Mar 7

Localised Radiation Treatment May Be the only hope for King Charles in His Greatest Battle Yet

Mar 7

Robin Stocksworth

OncoSil Medical Marks Milestone with Successful Pancreatic Cancer Treatment

OncoSil Medical (ASX: OSL) has marked a critical milestone by successfully treating pancreatic cancer in Europe with its flagship OncoSil…

Jan 22

OncoSil Medical Marks Milestone with Successful Pancreatic Cancer Treatment

Jan 22

Robin Stocksworth

OncoSil Medical Marks Milestone with Successful Pancreatic Cancer Treatment

OncoSil Medical (ASX: OSL) has marked a critical milestone by successfully treating pancreatic cancer in Europe with its flagship OncoSil…

Jan 16

OncoSil Medical Marks Milestone with Successful Pancreatic Cancer Treatment

Jan 16

Robin Stocksworth

OncoSil Medical Ltd. Advances Pancreatic Cancer Treatment with Percutaneous Clinical Trial

An important milestone has been reached when the ethics committee approved the ground-breaking PANCOSIL clinical study for OncoSil Medical…

Jan 15

OncoSil Medical Ltd. Advances Pancreatic Cancer Treatment with Percutaneous Clinical Trial

Jan 15

Robin Stocksworth

Robin Stocksworth

Your daily dose of market insights and stock wisdom. Stay ahead of the game with expert analysis and tips for successful trading.

Following

Help
Status
About
Careers
Press
Blog
Privacy
Terms
Text to speech
Teams